Germ cell migration in zebrafish is dependent on HMGCoA reductase activity and prenylation by Thorpe, J. et al.
Developmental Cell, Vol. 6, 295–302, February, 2004, Copyright 2004 by Cell Press
Short ArticleGerm Cell Migration in Zebrafish
Is Dependent on HMGCoA
Reductase Activity and Prenylation
PGC migration in zebrafish can be divided into several
steps that appear to rely on the integrity of specific somatic
structures. During somitogenesis, bilateral clusters of
PGCs migrate posteriorly until they reach the anterior
of the yolk extension, the position where the gonad
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Philadelphia, Pennsylvania 19107 develops (Weidinger et al., 2002). Recently, the chemo-
kine SDF-1a (stromal cell derived factor 1a) (Doitsidou2 Germ Cell Development
Max Planck Institute for Biophysical Chemistry et al., 2002) and its receptor CXCR4b (Doitsidou et al.,
2002; Knaut et al., 2003) were identified as moleculesAm Fassberg 11
37077 Go¨ttingen essential for proper migration of zebrafish PGCs. When
expression of cxcr4b or its ligand is inhibited, the migra-Germany
tion of germ cells is disrupted, indicating that SDF-1a
acts as a potent chemoattractant for zebrafish PGCs.
In the present study, we used statins, a class of potentSummary
competitive HMGCoAR inhibitors (Evans and Rees, 2002),
to show that HMGCoAR activity is also required for verte-Hydroxymethylglutaryl coenzyme A reductase (HMG
CoAR) is required for isoprenoid and cholesterol bio- brate PGC migration. We found that the effect of statins
could be overcome by injection of mevalonate but notsynthesis. In Drosophila, reduced HMGCoAR activity
results in germ cell migration defects. We show squalene, indicating that cholesterol and its immediate
precursors are not required for PGC migration. Furtherthat pharmacological HMGCoAR inhibition alters ze-
brafish development and germ cell migration. Em- analysis of downstream components of the mevalonate
pathway including the geranylgeranyl transferase 1bryos treated with atorvastatin (Lipitor) exhibited germ
cell migration defects and mild morphologic abnor- (GGT1), an enzyme responsible for the prenylation of
proteins, suggests that geranylgeranylation is essentialmalities. The effects induced by atorvastatin were
completely rescued by prior injection of mevalonate, for correct PGC migration.
the product of HMGCoAR activity, or the prenylation
precursors farnesol and geranylgeraniol. In contrast, Results
squalene, a cholesterol intermediate further down
the pathway, failed to rescue statin-induced defects. Cloning of Zebrafish HMGCoAR Orthologs
Moreover, pharmacologic inhibition of geranylgeranyl To examine a possible role of HMCCoAR in zebrafish
transferase 1 (GGT1) protein prenylation activity also PGC migration, we identified partial cDNAs of two
resulted in abnormal germ cell migration. Thus, our HMGCoAR orthologs (hmgcr1 and hmgcr2) (Supple-
pharmacological inhibition-and-rescue approach pro- mental Figure S1 [http://www.developmentalcell.com/
vided detailed information about the elements of iso- cgi/content/full/6/2/295/DC1]). Maternal hmgcr2 tran-
prenoid biosynthesis that contribute to germ cell mi- scripts were evident in 4-cell stage embryos and uniform
gration. Together with data from Drosophila (Santos expression was observed during gastrulation, suggesting
and Lehmann, 2004, this issue), our results highlight that the translated protein is present where PGCs migrate.
a conserved role for protein geranylgeranylation in hmgcr1 expression was observed in the liver and intestine
this context. of day 4 embryos and not at earlier stages.
Introduction HMGCoAR Is Required for Proper PGC Migration
To determine the effects of HMGCoAR during vertebrate
A key regulatory step in the synthesis of cholesterol is development and PGC migration, we incubated early
the reduction of hydroxymethylglutaryl-Coenzyme A to stage zebrafish embryos (2–4 hr post fertilization [hpf])
mevalonate by the enzyme Hydroxymethylglutaryl coen- in media containing statins. Embryos treated overnight
zyme A reductase (HMGCoAR) (Figure 1) (Sever et al., with either mevinolin (Lovastatin) or simvastatin (Zocor)
2003). Evidence from studies in Drosophila indicates exhibited developmental arrest, improper axis elonga-
that there are cholesterol-independent developmental tion, and compressed somites (Supplemental Figure
defects associated with genes in the mevalonate path- S2). The developmental arrest and axis elongation phe-
way. In flies lacking HMGCoAR, primordial germ cells notypes along with the EC50s of these phenotypes were
(PGCs) fail to reach their correct target in the mesoderm identical for both drugs. After mevinolin or simvastatin
(Van Doren et al., 1998). Importantly, cholesterol or its treatment, PGCs were widely dispersed, whereas un-
derivatives do not participate in producing the signal treated animals had a compact cluster of PGCs in the
required for germ cell migration, because Drosophila anterior yolk extension (data not shown). To demon-
lacks a number of enzymes necessary for de novo cho- strate that the PGC migration phenotype represented a
lesterol synthesis (Santos and Lehmann, 2004). primary defect in this process and was not due to de-
fects in somatic patterning (Supplemental Figure S2),
embryos were treated with atorvastatin, the only statin*Correspondence: sfarber@mail.jci.tju.edu
3These authors contributed equally to this work. that lacked a somatic phenotype in our assay (Figure 2).
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Figure 1. Cholesterol and Isoprenoid Biosynthesis Pathway
Atorvastatin treatment resulted in impaired PGC mi- HMGCoAR activity; see Figure 1) prior to statin treat-
ment. Mevalonate injections resulted in a complete res-gration (Figures 2A–2C) without the severe morphologi-
cal defects observed with the other statins (Figure 2D). cue of the PGC migration phenotype caused by all three
statins (Figure 3C). As a control, embryos were injectedEmbryos treated with atorvastatin showed a PGC migra-
tion phenotype at the end of gastrulation, resulting in with sodium citrate, a salt with a similar molecular weight
as mevalonate, prior to statin treatment, and this failedPGCs that failed to align along the anterior and lateral
borders of the trunk mesoderm. By the 3-somite stage, to reverse the PGC phenotype (data not shown). Mevalo-
nate not only reversed the PGC migration defects causedover 90% of the embryos had ectopic germ cells com-
pared to less than 20% in the wild-type (Figure 2E). by statin treatment, but also fully rescued the somatic
phenotype caused by mevinolin and simvastatin (FigureFurthermore, the effect of atorvastatin on PGC migration
was dose dependent (EC50 4M) (Figure 2F). As develop- 3D). Thus, both PGC migration as well as embryonic pat-
terning require components of the HMGCoAR pathway.ment proceeded, some of the ectopic PGCs eventually
migrated to the correct location, but still, by 24 hr, more Moreover, these data suggest that HMGCoAR activity
does not provide directional information to PGCs sincethan 50% of the treated embryos had ectopic PGCs
(compared to less than 10% in the wild-type) (Figure its product, mevalonate, can allow proper PGC migra-
tion even when it is uniformly applied.2E). Time-lapse studies of atorvastatin-treated embryos
indicate that GFP-labeled PGCs were motile (Figures
2G and 2H and Supplemental Movie S1). This suggests Injections with Farnesol and Geranylgeraniol
that inhibition of HMGCoAr activity leads to PGC migra- Rescue Atorvastatin Effects
tion defects either by affecting the speed of migration Mevalonate is utilized to synthesize a variety of cellular
or by impairing directional migration. compounds that include ubiquinones, carotenoids, iso-
prenoids, and cholesterol (Santos and Lehmann, 2004).
To determine directly whether cholesterol or its deriva-Rescue of Statin-Induced Defects by Mevalonate
To examine the specificity of the statin-induced effects tives played a role in zebrafish PGC migration, we tested
squalene, an intermediate in the pathway specificallyand provide evidence that the observed phenotype re-
sulted from the inhibition of HMGCoAR, we injected required for de novo cholesterol synthesis (Figure 1).
Squalene injection failed to rescue the effects of statinembryos with mevalonate (the immediate product of
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Figure 2. Migration of Primordial Germ Cells Is Altered by Atorvastatin Treatment
(A) A single fluorescent image from a time lapse (1-somite stage, first capture) of the movement of PGCs in a wild-type embryo injected at
the 1-cell stage with gfp-nanos mRNA (1–2 nl, 60 ng/l).
(B) Embryos (1-somite stage) soaked in atorvastatin (10 M) and injected with gfp-nanos mRNA exhibit ectopic PGCs that fail to cluster.
(C) Later stage embryos (22-somite stage) exhibit many ectopic germ cells following atorvastatin (10 M) treatment.
(D) Brightfield image of an embryo (24 hpf) injected with gfp-nanos mRNA and treated with atorvastatin (10M) that exhibits only a mild tail defect.
(E) Analysis of the effect of atorvastatin treatment on PGC migration at different developmental stages. The number of embryos at a given
stage with more than two ectopic PGCs was determined and expressed as a percent of the total number of embryos examined (n  64–84
for each stage).
(F) The effect of atorvastatin on numbers of ectopic PGCs is dose dependent. Embryos were soaked in atorvastatin (10 M). At 24 hpf,
embryos were each scored on the degree of ectopic PGCs (a level 1 embryo had a wild-type single gonadal cluster and a level 4 embryo had
no discernable cluster). Data represent the mean  SEM from three to four experiments/dose.
(G) Initial image from a time-lapse movie of an atorvastatin-treated (10 M) embryo, taken at the 14-somite stage.
(H) Three captured images from the time-lapse movie as in (G) taken at 1, 50, and 80 min after the 14-somite stage.
treatment (data not shown), suggesting that cholesterol- is readily converted to geranylgeranyl diphosphate
(Crick et al., 1994) prior to statin treatment exhibitedindependent compounds of the HMGCoAR pathway
control PGC migration. normal PGC migration and were as equally protected
as embryos injected with mevalonate (Figure 3E). Farne-To test whether the isoprenoid synthesis branch of the
pathway (via geranylgeranyl transferases and farnesyl sol is an alcohol that can elevate cellular farnesyl diphos-
phate, a precursor required both by geranylgeranyltransferases) mediates the effect of statins on PGC
migration, we injected embryos with compounds that transferase and farnesyl transferase (Figure 1). Injection
of farnesol also rescued the PGC migration defect ofwould increase the cellular levels of the substrates of
these enzymes before immersion in atovastatin (10 M). embryos from statin treatment (Figure 3E). Our results
support the idea that the PGC migration defect inducedEmbryos injected with geranylgeraniol, an alcohol that
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Figure 3. Injection of Isoprenoid Intermediates Abrogates the Effects of Statins
(A) Uninjected embryos show severe developmental defects after 24 hr of mevinolin (1.2 M) treatment.
(B) Embryos injected at early cell stages (1–16 cell stage) with mevalonate (1–2 nl, 0.5 M) and then soaked in mevinolin (1.2 M, 24 hr) exhibit
normal morphology.
(C) The appearance of ectopic PGCs following statin treatment is prevented by mevalonate injections. Embryos at early cell stages were
injected with gfp-nanos mRNA and mevalonate as in (B) and soaked overnight in statin drugs (mevinolin [1.2 M], simvastatin [2.0 M], and
atorvastatin [10 M]). At 24 hpf, the PGC score was determined. Data represent the mean  SEM from three to four experiments.
(D) Mevalonate injection rescues the somatic defects observed in embryos treated with statins. Embryos at early cell stages were injected
with mevalonate as in (B) and soaked overnight in statin drugs: mevinolin (1.2 M), simvastatin (2.0 M), and atorvastatin (10 M). At 24 hpf,
developmental defects were scored. Data represent the mean  SEM from three to four experiments.
(E) Embryos injected at the 1–16 cell stage with farnesol (1–2 nl, 1 M), geranylgeraniol (0.5–1 nl, 1 M) or mevalonate (1–2 nl, 0.5 M) and then
soaked overnight with atorvastatin (10 M) show normal PGC migration. Statistics were performed using ANOVA with a post hoc test that
utilizes a Bonferroni correction. Data represent mean  SEM, * p  0.01 difference from atorvastatin alone.
by statins is the result of impaired geranylgeranylation Geranylgeranyl Transferase Activity Is Required
for Correct PGC Migrationof target proteins caused by reduction in cellular gera-
nylgeranyl diphosphate (Figure 1). Furthermore, these To examine whether geranylgeranyl transferase (GGT1)
or farnesyl transferase activities influence PGC migra-results are consistent with genetic studies in Drosophila
where mutations in geranylgeranyl diphosphate syn- tion, embryos were treated with different doses of spe-
cific inhibitors and the position of PGCs was determinedthase and farnesyl diphosphate synthase, the enzymes
that produce farnesyl diphosphate and geranylgeranyl after 1 day of development. High doses of the selective
farnesyl transferase inhibitor FTI-2153 (FTase IC50, 1.4diphosphate, respectively, result in germ cell migration
defects (Santos and Lehmann, 2004). nM over GGT I IC50, 1700 nM) (Crespo et al., 2001; Sun
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et al., 1999) had no effect on PGC migration (data not migration in zebrafish depends on HMGCoAR activity
shown). A second farnesyl transferase inhibitor (L-744) and isoprenylation is consistent with studies in Drosoph-
(Kohl et al., 1995) also had no effect on PGC migration ila (Santos and Lehmann, 2004; Van Doren et al., 1998)
(data not shown). In contrast, injection of a selective and suggests that this pathway is evolutionarily con-
inhibitor of GGT1 (GGTI-2166, 100-fold more selective served.
at inhibiting Rap1A [IC50, 300 nM] over farnesyl trans- Understanding the mechanisms that regulate PGC mi-
ferase as measured by H-Ras processing) (Sun et al., gration is likely to help formulate a general model for
1999) caused a strong PGC migration phenotype (Fig- long-range cell migration during development and dis-
ures 4A–4D) and only mild morphological defects, which ease. This is illustrated by the observation that the che-
were manifested as a slight kink in the notochord (Figure mokine, SDF-1, and its receptor, CXCR4, provide guid-
4D, arrowhead). ance cues to direct PGCs to the developing gonad of
The effect of GGTI-2166 on PGC migration was dose mice and fish (Ara et al., 2003; Doitsidou et al., 2002;
dependent (approximate EC50 30 M) (Figure 4E). To Molyneaux et al., 2003) and that a receptor related to
determine the cellular basis for the GGTI-2166-induced CXCR4 is required for PGC migration in Drosophila
abnormal cell migration, the behavior of GFP-labeled (Kunwar et al., 2003). Further, a number of reports indi-
PGCs was analyzed by time-lapse microscopy (Supple- cate that SDF-1 plays a critical role in determining the
mental Movies S2 and S3). The formation of cellular destination of metastatic tumor cells (Muller et al., 2001)
protrusions was normal in PGCs treated with GGTI- and the migration of other cell types during development
2166. However, a significant reduction in the migration (Peled et al., 1999).
speed in treated PGCs was observed (from 2.170  The parallels between proteins that influence PGC
0.155 to 1.515 0.095m/min in GGT1-treated embryos migration and those that regulate cancer cell metastasis
p 0.001). These data suggest that protein prenylation, are further substantiated by our observation that inhibi-
specifically by GGT1, is required for correct PGC migra- tion of GGT1 results in altered PGC migration. Several
tion and that HMGCoAR activity is needed to provide studies find that statins or specific prenylation inhibitors
GGT1 substrates. impair the chemotactic migration of cancer cells (Mor-
To assess the potential role of GGT1 activity on PGC gan et al., 2003), the migration of human monocytes
migration, we identified the zebrafish ortholog of this (Wong et al., 2001), and the migration of lymphocytes
gene. Zebrafish GGT1 is approximately 70% identical (Walters et al., 2002).
to the human ortholog at the amino acid level (Supple- The present study utilizes highly specific enzyme in-
mental Figure S3). Similar to hmgcr2 expression, mater- hibitors to identify likely regulators of PGC migration.
nal ggt1 transcripts were evident in 4-cell stage embryos This approach has a number of advantages in that multi-
and uniform expression was observed during gastrula- ple isoforms and not individual proteins can be targeted.
tion (Supplemental Figures S1 and S3). These data sug- Additionally, when genetic studies impair zygotic gene
gest that GGT1 is present in positions where the PGCs expression, residual maternally derived protein, which
migrate. may be experimentally difficult if not impossible to
eliminate, can mask the corresponding phenotype. Con-
Do SDF-1 and HMGCoAR Act in the Same Pathway versely, it can be difficult to establish that the phenotype
to Regulate PGC Migration? resulting from soaking whole embryos in a pharmaco-
Previously, it was shown that the G protein-coupled logic reagent results from the specific inhibition of a
receptor CXCR4b and its ligand SDF-1a provide direc- protein or protein family. We addressed this issue by
tional guidance cues to migrating PGCs. One possibility injecting embryos with mevalonate prior to their expo-
to explain the effect of statin treatment on PGC migration sure to statins. This procedure rescued all phenotypes
could be that HMGCoAR activity is required for the ex-
associated with statin treatment, supporting the notion
pression or activity of the SDF-1 ligand. We therefore
that the observed effect is specific to the mevalonate
analyzed the expression of sdf-1a in statin-treated em-
pathway (Figure 3).bryos and found that atorvastatin treatment did not alter
Although mevalonate rescued the effect of all the stat-sdf-1a expression (Figures 4F and 4G). To further test
ins utilized in this study, the phenotypes induced byif statins and the SDF-1a receptor CXCR4b function
the different statins were not identical. Simvastatin andtogether or independently, we impaired both pathways
mevinolin produced more severe somatic phenotypesby injecting atorvastatin and morpholino antisense oli-
than atorvastatin, one of the most hydrophobic statins.gonucleotides directed against cxcr4b (Heasman et al.,
One possibility is that atorvastatin partitions into the2000; Nasevicius and Ekker, 2000). Doses were selected
yolk, which may limit both the availability and concentra-to induce mild migration defects. The combined effect
tion of the drug within the embryo.of atorvastatin and cxcr4b morpholino was not greater
Our observation that atorvastatin-induced PGC mi-than the sum of each independent treatment (Figure
gration defects were rescued by both geranylgeraniol4H), indicating that HMGCoAR and SDF-1a function in
and farnesol points to a potential role for geranylgeranyldistinct pathways.
transferase or farnesyl transferase activities in this pro-
cess. However, two farnesyl transferase inhibitors failedDiscussion
to show any effect on PGC migration, while a GGT1-
specific inhibitor (Sun et al., 1999) demonstrated a roleThe results of this study indicate that pharmacologic
for geranylgeranylated rather than farnesylated proteinsinhibition of protein prenylation, either through the inhi-
in the process. The fact that farnesol also rescued ator-bition of GGT1 directly or by limiting the supply of pre-
vastatin-induced migration defects could be due to thecursors for the reaction it catalyzes, impairs the migra-
tion of PGCs. The observation that correct PGC presence of enough cellular isopentenyl diphosphate
Developmental Cell
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Figure 4. GGT1 Activity Is Required for PGC Migration
(A) A fluorescent image of a wild-type embryo (24 hpf) injected with gfp-nanos mRNA at the 1-cell stage reveals a cluster of PGCs.
(B) A brightfield image of the embryo in (A).
(C) A fluorescent image of an embryo (24 hpf) that was injected with gfp-nanos mRNA at the 1-cell stage and immediately soaked in the
geranylgeranyl transferase inhibitor (GGTI-2166; 40 M), resulting in ectopic migration of many PGCs.
(D) A brightfield image of the embryo in (G) showing a mild notochord defect (arrowhead).
(E) Dose response of GGTI-2166 on PGC migration defect. Data represent the mean  SEM from three to six experiments for each dose.
sdf-1a expression is not altered in atorvastatin-treated embryos. A two-color whole mount in situ hybridization experiment was performed
using sdf-1a (brown) and nanos-1 (blue, marks germ cells) antisense riboprobes on wild-type (F) and atorvastatin-treated embryos (G).
(H) Embryos injected with a cxcr4b morpholino to inhibit translation of cxcr4b exhibited a PGC phenotype that is additive with atorvastatin
treatment. All embryos were injected with gfp-nanos mRNA and a control morpholino (1–2 nl, 0.02 mM) or cxcr4b morpholino (1–2 nl, 0.02
mM) at the 1-cell stage. Half of the injected embryos from each group were immediately treated with atorvastatin (4.0 M) or embryo medium.
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Sigma Chemical), geraynlgeraniol (1 M, Sigma Chemical) and/or gfp-(even after HMGCoA reductase inhibition) such that far-
nanos mRNA. Phenol red solution (0.2% final concentration) wasnesyl diphospate can be converted to geranylgeranyl
added to all injection solutions to visualize injected embryos. Typi-diphosphate by the action of geranylgeranyl diphos-
cally, embryos were initially injected with gfp-nanos mRNA and then
phate synthase (see Figure 1). sorted into groups that were subject to a second injection of mevalo-
Despite the striking conservation for the role of nate or buffer.
HMGCoAR in Drosophila and zebrafish PGC migration, an
important difference between the two systems should be Farnesyl and Geranylgeranyl Transferase Inhibitors
Ras farnesyltransferase inhibitor (L744; Sigma) was made up to anoted. In Drosophila, the expression pattern of HMGCoAR
final concentration of 4 mM. 1-cell stage embryos were injectedcan determine the direction of PGC migration. In zebra-
with 1–2 nl of farnesyltransferase inhibitor and 1–2 nl of gfp-nanosfish, however, the spatial distribution of HMGCoAR ac-
mRNA. Some embryos were also soaked in farnesyltransferase in-
tivity fails to provide the PGCs with directional cues hibitor overnight. GGT1 inhibitor GGTI-2166 (Mol. Wt. 434.53) and
since zebrafish HMGCoAR genes are not specifically farnsyl transferase inhibitor FTI-2153 (Mol. Wt. 539) were resus-
expressed in regions toward which the PGC migrate pended in DMSO (50 mM).
(Supplemental Figure S1) and uniform application of
mevalonate simply rescued rather than interfered with Microscopy
Embryos were anesthetized (Tricaine, 170 g/ml) and placed onPGC migration. One possibility is that HMGCoAr activity
depression slides. Images were taken on a Zeiss Axio Vision 3.0merely provides a factor necessary for PGC migration,
Camera mounted on a Leica MZFL-III stereomicroscope. Some im-while directional cues are under the sole control of
ages were captured using a Zeiss Axio Vision 3.0 camera mounted
SDF-1a (Doitsidou et al., 2002). Alternatively, while iso- on a Zeiss Axioplan II microscope.
prenylation itself may not be spatially controlled, the
target of its function, i.e., the substrate for isoprenyla- Acknowledgments
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